Deutsche Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Deutsche Bank’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-750	Closed	-$11K	–	5527
2015 Q1	$11K	Hold	750	–	–	﹤0.01%	4790
2014 Q4	$9K	Buy	+750	New	+$8.57K	﹤0.01%	5745
2014 Q3	–	Sell	-750	Closed	-$9K	–	6187
2014 Q2	$9K	Buy	+750	New	+$8.86K	﹤0.01%	5531
2013 Q3	–	Sell	-750	Closed	-$2K	–	5813
2013 Q2	$2K	Buy	+750	New	+$9.9K	﹤0.01%	5201

Deutsche Bank's MNTA Position: Q4 2020 in Review

Deutsche Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 143,825 shares — an estimated $7.55M sold.

Deutsche Bank first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $8.07M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Deutsche Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Deutsche Bank sold 143,825 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.55M.
Deutsche Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
Deutsche Bank's Momenta Pharmaceuticals, Inc. position peaked at $8.07M in Q3 2018.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.